About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×

news

Company News Events Insights Webinars Virtual Tours

Salubris Pharmaceuticals SAL0119 IND Application for Treatment of Ankylosing Spondylitis and Rheumatoid Arthritis Accepted by FDA

Salubris Pharmaceuticals SAL0119 IND Application for Treatment of Ankylosing Spondylitis and Rheumatoid Arthritis Accepted by FDA | BioDuro-Sundia
June 30, 2023

BioDuro-Sundia Forms Strategic Partnership with GS Capsule

BioDuro-Sundia and GS Capsule forge a strategic partnership at CPHI China, enhancing drug formulation and packaging innovations for global healthcare solutions.
June 19, 2023

BioDuro-Sundia Wins Life Sciences Review Top 10 BPO Award

BioDuro-Sundia honored as a top 10 BPO by Life Sciences Review for its premier CRDMO services and commitment to client-focused innovation. Moving you Forward
April 03, 2023

BioDuro-Sundia Announces Formation of Scientific Advisory Board

Announcing today the establishment of a Discovery Research Scientific Advisory Board (SAB) with the appointment of Andrew Thomas Ph.D. and Zach Sweeney Ph.D.
March 27, 2023

BioDuro-Sundia Forms Strategic Partnership with Kanwhish

To promote a long-term mutually beneficial strategic partnership, we have recently signed a strategic cooperation agreement with Suzhou Kanwhish Biotechnology
March 20, 2023
Total 85 12345678...1617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all